Technical Analysis for PTN - Palatin Technologies, Inc.

Grade Last Price % Change Price Change
grade B 0.8178 0.96% 0.01
PTN closed up 0.96 percent on Thursday, October 19, 2017, on 88 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PTN trend table...

Date Alert Name Type % Chg
Oct 17 NR7 Range Contraction 9.55%
Oct 16 Spinning Top Other 9.04%
Oct 13 Hammer Candlestick Bullish 10.51%
Oct 13 1,2,3 Pullback Bullish Bullish Swing Setup 10.51%
Oct 13 MACD Bearish Signal Line Cross Bearish 10.51%

Older signals for PTN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Get Started for Free!
Basic chart:

Profile
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Is PTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 5 Palatin Technologies (PTN) in Focus: Stock Moves 13.2% Higher
Oct 4 Earnings Review and Free Research Report: Neogen’s Revenue Jumped 14%; Net Income Surged 21%
Sep 27 Edited Transcript of PTN earnings conference call or presentation 25-Sep-17 3:00pm GMT
Sep 26 ETFs with exposure to Palatin Technologies, Inc. : September 26, 2017
Sep 25 Investor Network: Palatin Technologies, Inc. to Host Earnings Call
Sep 25 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2017 Results; Teleconference and Webcast to be held on September 25, 2017
Sep 20 Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2017 Results; Teleconference and Webcast to be held on September 25, 2017
Sep 12 Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors
Sep 6 Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories
May 16 Edited Transcript of PTN earnings conference call or presentation 16-May-17 3:00pm GMT
See more PTN news...
Indicators
Indicator Value
52 Week High 0.9
52 Week Low 0.2851
Average Volume 2,529,888
200-Day Moving Average 0.4436
50-Day Moving Average 0.5877
20-Day Moving Average 0.7427
10-Day Moving Average 0.796
Average True Range 0.0604
ADX 35.29
+DI 34.52
-DI 19.05
Chandelier Exit (Long, 3 ATRs ) 0.7088
Chandelier Exit (Short, 3 ATRs ) 0.7612
Upper Bollinger Band 0.903
Lower Bollinger Band 0.5824
Percent B (%b) 0.73
BandWidth 43.166824
MACD Line 0.0585
MACD Signal Line 0.0649
MACD Histogram -0.0064
Fundamentals Value
Market Cap 146.42 Million
Num Shares 179 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -9.85
Price-to-Sales 3.40
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.93
Resistance 3 (R3) 0.94 0.90 0.91
Resistance 2 (R2) 0.90 0.87 0.90 0.91
Resistance 1 (R1) 0.86 0.85 0.84 0.86 0.90
Pivot Point 0.82 0.82 0.81 0.82 0.82
Support 1 (S1) 0.78 0.79 0.76 0.78 0.73
Support 2 (S2) 0.75 0.77 0.74 0.73
Support 3 (S3) 0.70 0.75 0.72
Support 4 (S4) 0.70